Four years ago, the first acoustic droplet ejectors (ADEs) were launched on the market, providing a new generation of highthroughput noncontact liquid handlers that outclassed traditional contact instruments in almost every respect. This introduction of noncontact dispensing has triggered radical changes to the screening/compound management interface. Higher quality is achieved through greater accuracy and precision, whereas lower sample volumes can be used, and 1536 plate formats have become a reliable reality. Prior to the ADE instrument launch, 1536 assay-ready plate preparation was a high-effort enterprise requiring users to spend time developing liquid-handling methods along with daily fine-tuning of instruments to reach the desired level of performance. By overcoming the nanoliter dispensing hurdle and successfully transferring assays to high-density formats, a new dimension for cutting costs has emerged. Once the screening customer has adapted to this new world, the rules of supply can also change, with the traditional automated plate store no longer being necessary when the compound library can be stored in 1536 plates. Processing efficiency recently has been further supported by innovative new automation-friendly solutions such as plate desealers, prolonging the life span of working plate copies. Both cost and waste control have never had a higher profile, and noncontact dispensing contributes to these important areas. In some processes (e.g., when piercing septa), contact dispensing remains the best option, but cost control is still essential, and an innovative solution to minimize DMSO consumption from tip washing has had a big impact on consumable budget without compromising quality. (Journal of Biomolecular Screening 2009:509-514) 
INTRODUCTION
I n its infancy in the early 1990s, compound management (CM) was a low-key, error-prone, nonautomated discipline with no standardized best practice. Since then, CM has evolved and undergone several major transformations, leading to today's heavily automated discipline supported by a backbone of highly sophisticated informatics systems that in turn are integrated with core business applications. 1, 2 One of the major drivers behind this metamorphosis was the realization that leads coming out of the drug discovery process were simply not better than the chemical entities that entered. This was an unpleasant but necessary wake-up call for most pharmaceutical companies, leading to many initiatives and investments with the aim to reinvent compound management as a science. [3] [4] [5] In the wake of these investments, resulting in large bespoke systems capable of cherry-picking several hundred thousand samples per week, the climate around the drug discovery industry has changed from one where investment was made as required to one where cost control is essential.
If a process being supported is relatively static over time, it is possible for it to be automated, and following optimization, areas can be identified where costs can be reduced. Unfortunately, the marriage between high-throughput screening (HTS) and CM is far from a static process. It is rather a technology devouring relationship where both parties constantly break new ground by introducing new technologies, such as new screening formats and acoustic droplet ejectors (ADEs). The main reason for this coevolution is a common strive to shorten cycle times for HTS campaigns, increase quality of data output, and, paradoxically, reduce costs. At first, this might sound like an ideal situation for cutting costs, but after digging further into this topic, it becomes evident that most new technologies implemented are associated with expensive capital investments that in turn put pressure on the other partner to invest and adapt to the new process that results.
In this article, we present 3 areas where significant improvements have been achieved when dealing with quality, speed, and cost from a CM perspective. First, the impact of introducing 1536 as the primary screening format is discussed and how it has contributed to shorter timelines and reduced costs. Second, compound degradation in microplates due to water uptake has always been a hot topic. 6, 7 The technology to solve this problem is available on the market, but it is not always as cost-effective and flexible as the business would like it to be. We believe that an automated desealer can fill this gap. Third, we describe our in-house tip wash system that has reduced our DMSO consumption by 75%. All of these approaches are of high relevance to HTS, and the utilization of these technologies is spreading to other functions such as drug metabolism and pharmacokinetics (DMPK) and secondary screening activities. 8
MATERIALS AND METHODS

Impact of the 1536 format on compound management
The Results and Discussion section, unless otherwise indicated, is based on throughput figures along with consumable and instrument costs all taken from the compound supply and HTS process at AstraZeneca R&D Mölndal, Sweden.
Maintaining compound integrity in microplates by introduction of an automated desealer in the plate preparation process
The existing compound supply process that supports HTS operation at AstraZeneca R&D Mölndal allows for water uptake to occur at 2 different stages. (1) Unsealed plates are loaded onto a stacker where the top plate, being empty, acts as a lid. On average, plates spend 6 h here before they are processed by an Echo  555 liquid handler from Labcyte (Sunnyvale, CA). (2) Plate replication takes on average 9 min, including barcode logging, loading/unloading the ADE, and heat sealing of processed plates with a PlateLoc  from Velocity11 (Santa Clara, CA). During replication, the plates are fully exposed to the surrounding environment, as there is no plate acting as a lid.
A total of six Corning  1536 Well Echo  Qualified Micropl ates (Corning, NY) were filled with 5 µL of DMSO with a Velocity11 384 fixed tip head VPrep  and divided into 2 sets of triplicates. One set was exposed to processes 1 and 2 and the other, with the purpose of mimicking an integrated desealer from Nexus Biosystems (Poway, CA), only to process 2. Both sets were handled at 22 °C and 30% relative humidity (RH), for an equivalent of 10 HTS campaigns (i.e., the processes mentioned above were repeated 10 times for each set of plates). The water uptake and evaporation that take place in heat-sealed plates during storage were said to be negligible when compared to the effects of exposing samples directly to the surrounding environment. The water content of plates was determined with an Echo  555.
Reducing costs by an optimized pipette tip wash procedure
The liquid handler used for the evaluation of the new wash procedure was a Velocity11 384 fixed tip head VPrep  with 2 chimney wash stations. A 5-L plastic bottle was used as the DMSO recycle container with 2 tube connectors for inflow, 1 for outflow taking liquid 50 mm from the bottom of the container and 1 overflow drain to empty 75% of the container by gravity when the liquid level reaches the top.
For the optimization of the wash procedure, a statistical experimental design was created using MODDE  6.0 by Umetrics AB (Umeå, Sweden).
The experiments were performed by pipetting 1 µL fluorescein in DMSO 3 times followed by the wash protocol and thereafter pipetting 6 µL of fresh DMSO into a Greiner 384 PS black 781076 plate (Greiner BioOne, Germany), where 80 µL of purified water was added and read at excitation 485 nm and emission 535 nm in a SpectraFlour Plus reader (Tecan Trading AG, Switzerland). The optimal protocol parameters found, following a 1-µL transfer, were 6 mix cycles in the recycle wash with 80% pump speed followed by 3 mix cycles in the fresh DMSO wash station at a pump speed of 20%. All mix cycles consisted of aspirating and dispensing the complete pipette volume of 50 µL.
To validate a carryover free wash, we dispensed a selection of 1536 compounds, with known activity in an enzyme absorbance assay used in a recent HTS campaign, in 1 µL of a 10-mM DMSO solution into a Greiner 384 PS plate followed by the wash protocol. After this, 1 µL of DMSO was dispensed in the same way. The plates were screened at a 125-µM compound concentration to create an extreme situation. The activity distribution from the DMSO plates was compared with the sample plates as well as a reference plate.
RESULTS AND DISCUSSION
Impact of 1536 on compound management
During the past decade, implementing the 1536 format as a screening standard has been the ultimate technology goal for HTS labs in the industry and is now finally starting to become a reliable reality. 9, 10 Screening in a 1536-well format compared to 384 and 96 brings many advantages and benefits, the most significant being shorter lead times and reduced reagent costs.
What benefits has the 1536 format brought to the compound management society, then? Initially, low-volume screening plates were prepared by wet dispensing volumes with traditional contact instruments, thereby limiting the volumes that could be delivered with great accuracy and precision to around 100 nL. At one point, pin tools were considered, but the shape of things to come looked slightly different.
Screening in 1536 plates has been around for the past decade, but what really fully enabled the high-density format revolution within CM and HTS at AstraZeneca was the development of acoustic droplet ejectors. This new generation of noncontact liquid handlers, capable of transferring aliquots of 2.5 nL of DMSO-solubilized samples with high accuracy and precision, 11 did not require any time to be spent by users to optimize dispensing parameters, a task that potentially could take days or weeks and quite often required the instrument to be adjusted on a daily basis. Another advantage with the ADE technology is the fact that liquids are transferred with sound, sending all DMSO wash stations to the discard pile along with consumables such as pipette tips. During an HTS, pipette head tips are thoroughly washed between each sample transfer, resulting in approximately 3000 head wash operations for a 1M compound screen. A DMSO wash cycle roughly costs $1 to $1.5, adding up to $4.5K saved for each screen.
The first ADE instrument launched for compound handling was the Labcyte Echo  550 that was able to prepare around 75 × 1536 plates per day and was soon joined by the ATS-100 from EDC Biosystems (Milpitas, CA). ADEs are expensive instruments, with prices typically ranging from $200K to $350K, depending on vendor and throughputs, and as always, the really interesting instruments with throughputs of 150 × 1536 plates per day can be found at the higher end of the scale.
An opportunity that reveals itself with the transition into a high-density format is the need or, more specifically, the lack of need of an automated plate store. Cherry-picking currently requires the use of highly automated stores with pick rates of several hundred thousand compounds per week, and it is not likely that this will change within a foreseeable future. 12, 13 However, until now, the same necessity for an automated storage and retrieval system has been the case for the efficient management of HTS working plate copies, typically consisting of 3000 plates. By introducing 1536 as a storage format, the number of plates in such a collection dramatically decreases to an amount that can be easily managed manually.
This might sound like a step backwards in an otherwise innovative discipline that has managed to automate a considerable amount of its processes, but as always, there are exceptions. A new high-speed replicating plate store requires an enormous effort from the users before the system can be said to be in full production. In-house experience of such projects is that delays of 12 to 18 months are often the case, mostly due to integration issues between the plate replicating platform and the storage module but also due to changes in the user requirements in the ever-changing drug discovery process. The risk here is that the expected life span of the system might have been decreased by the same amount of time as the system has been delayed. Heavily delayed systems may even be obsolete the day they are delivered, ending up as "white elephants." A high-speed plate replication store dimensioned for an HTS center in a major pharma may cost in the region of $3M to $4M, of which integration work stands for a considerable proportion.
It is in this context that the strength of a manual storage and retrieval system becomes obvious. Such a system is flexible, is cost-effective, and causes no interruptions to the plate preparation process due to database glitches.
Maintaining compound integrity in microplates by introduction of an automated desealer in the plate preparation process
One of the most resource-intensive and critical events in the AstraZeneca Mölndal CM calendar is the yearly rebuild of the working plate copy that later on is used in the preparation of assay-ready plates (ARPs) for HTS campaigns. Reasons for performing this exercise as often as once a year are sample depletion, the occasional screening library restratification according to trends within drug discovery, and decreased sample integrity during the year due to water uptake from the surrounding environment. 13 Today, the in-house cost of consumables for preparing a working plate copy in 1536 format is $28K.
We therefore established a study to determine whether the introduction of automated heat sealing and desealing in a plate replication process could prolong the life span of the AstraZeneca Mölndal working plate copy by maintaining compound integrity and thereby reduce costs and full-time equivalent time spent on its preparation. A desealer is a "generic solution" and does not involve any expensive tailor-made consumables (e.g., lids and plates) available only from one single supplier.
There are 2 undesired elements in the AstraZeneca R&D Mölndal plate preparation process supporting HTS. First, from a safety, health, and environment (SHE) perspective, daily manual removal of heat seals is a task that every highly automated lab should strive to get away from. Second, leaving the unsealed working plates stacked on top of each other for an average of 6 h per primary screen does not contribute to compound preservation no matter how small the screening format is. It is evident from Figure 1 that a considerable amount of water uptake from the surrounding environment takes place when plates await processing in the plate stackers. Another factor that aggravates matters even more are the edge effects that initially result from water uptake and later on due to evaporation, leading to erroneous concentration of compound in the destination plates (Fig. 2) .
A fully integrated automated desealer takes away the 2 undesired elements from the above ARP preparation process while also maintaining throughput figures. Water uptake is minimized and edge effects are significantly reduced after an automated desealer has been introduced to the process (Figs. 1, 2) . The water uptake that still can be observed takes place during the plate replication process and is thus unavoidable no matter what system is used (e.g., lids or cap mats).
Removing the need for an annual build of the working plate copy contributes to direct cost savings in the form of labware and DMSO. At AstraZeneca R&D Mölndal, this adds up to $28K for every year the build can be postponed, which is approximately the price of a desealer. Whether the AstraZeneca working plate copy needs to be rebuilt every 2 or 3 years still remains to be seen, but what is certain at this point is that a cost reduction has been achieved.
Reducing costs by an optimized pipette tip wash procedure
A great benefit with ADE is eliminating the risk of carryover without any cost for tip wash liquids. The limitation of ADE is the decrease in throughput at higher volumes (Fig. 3) , making further optimization of traditional dispensers a valid task.
A possibility for improvement is the cost of DMSO for tip washing, which makes a significant part of the budget in CM AstraZeneca R&D Mölndal. With the current setup, 100 mL DMSO is consumed per wash of a 384-tip pipetting head, and at a price of approximately $10 per liter, the total cost per year is high.
The consumption of several thousand liters of organic solvent will also contribute heavily to the environmental footprint from HTS screening, and a reduction would be a significant SHE opportunity.
What stops us from achieving lower DMSO consumption? The restricting factor would be a compromise in either quality or throughput. A compromise in quality in this case would be carryover. A compromise in throughput would need to be addressed by increasing the number of pipettors, and the cost reduction in consumables would be evened out with the capital investment needed.
The easiest way to deal with this problem would be to copy an existing solution, but unfortunately, no solution was found when comparing with other units performing the same tasks, and hence an in-house solution was developed.
First, the existing 1-step pipette tip wash was examined. The inside of the tip was efficiently washed by several mix cycles, 
FIG. 2.
Graphical representation of water uptake in a DMSO-filled 1536 working plate, whether or not a desealer is used. and the outside was washed by the flow of DMSO pumped through the chimneys along the outside of the tip (Fig. 4A) . In this case, the high flow rate was the cause of the high DMSO consumption. One thing to note was that the DMSO draining into the waste was not significantly contaminated, leading to the idea of creating a 2-step wash procedure.
The aim was to have 2 wash steps and recycle the DMSO (Fig. 4B,C) . The first wash step was set to use recycled DMSO, the second fresh DMSO. During the first wash step, it was possible to maintain a high flow rate as it did not contribute to an increased DMSO consumption. To find the optimal settings for pump speeds and mix cycles for the 2-step wash procedure, we conducted an experiment over the possible range of settings with the aim to optimize against DMSO consumption, time, and carryover. At this optimization stage, fluorescein was used as an indicator for carryover due to its properties as a worstcase scenario compound with an affinity to stick to pipette tips and the possibility to quantify down to a nanomolar detection range, which is needed during the optimization phase. A later validation experiment with a large set of compounds with diverse physical properties was needed to verify the wash procedure efficiency with a larger set of compounds. The validation experiment was performed by preparing plates with high-concentration compound solutions from a set of 1536 compounds interleaved with DMSO plates using the new wash in between. These plates were screened in an enzyme assay where the compounds were known to be active, and the results showed no sign of carryover ( Fig. 5A,B) .
The outcome of this optimization is a wash procedure with a 75% lower DMSO consumption at the same 40 s per wash throughput and quality as the previous wash.
CONCLUSION
This article highlights the importance of continuously adapting new technologies and innovative solutions to improve or reinvent processes with regard to quality, cost, and throughput. At a first glance, capital investments in technologies often appear as huge costs, but it is important to fully evaluate their long-term impact on the business because an expensive instrument (e.g., Echo  555 or ATS-100) might in fact be associated with reduced operating costs, leading to long-term savings. The 3 examples presented here have had a major impact on the plate preparation process at AstraZeneca R&D Mölndal. Investment in ADE instruments not only has made low-volume ARP preparation a routine task but also has increased quality in terms of accuracy and precision, further facilitating a laboratory's transition to the world of 1536. An additional benefit is the redundancy of the traditional working plate store when a 1536 working plate copy can easily be managed offline. An automated desealer has been shown to prolong the life span of working plates and simplified the process of preparing ARPs, and finally, an innovative optimization of an existing pipette tip wash procedure has reduced DMSO consumption by 75% while maintaining throughput. 
